サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566762

骨移植片と代替物市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Bone Grafts and Substitutes Market By Type , By Application By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
骨移植片と代替物市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

骨移植片と代替物市場は、2023年に28億米ドルと評価され、2024～2033年にかけてCAGR 4.4%で成長し、2033年には44億米ドルに達すると予測されています。

骨移植片と代替物は、さまざまな医療処置において欠損または損傷した骨を補うために使用される器具です。整形外科や脊椎手術において重要な役割を果たしています。骨移植片と代替物の主要目的は、新しい骨の成長のための足場を提供し、骨組織の修復と再生を強化することによって、身体の自然治癒プロセスをサポートすることです。このように、骨移植片と代替物は現代医療において重要な道具として機能し、様々な外科領域において患者の転帰を大幅に改善します。

骨移植片と代替物の世界市場の成長は、整形外科疾患の憂慮すべき発生率の増加、骨折やスポーツ傷害のケースの増加が主要要因です。オランダの情報サービス会社Wolters Kluwerが発表した調査によると、世界中で年間約200万件の骨移植手術が行われています。このうち米国だけで年間50万件の骨移植が行われています。さらに、高齢者人口の急増も市場成長に大きく寄与しています。高齢者は骨粗鬆症や関節炎などの骨関連疾患にかかりやすいです。これは、高齢者の骨に含まれるミネラルが流出し始め、骨がもろく壊れやすくなるためであり、そのため骨採取機が必要となります。世界保健機関（WHO）によると、60歳以上の高齢者数は2019年に10億人でした。この数は2030年までに14億人、2050年までに21億人に増加すると推定されています。さらに、骨移植片や代替物を使用することが多い低侵襲手術手技への嗜好のシフトが、市場の成長に顕著に寄与しています。さらに、特に新興国市場における医療支出の増加は、骨移植手技を含む高度な整形外科治療へのアクセスを向上させており、これが世界市場の大きな原動力となっています。しかし、骨移植術に伴う高コストと免疫拒絶反応のリスクが、世界市場の主要な阻害要因となっています。それとは逆に、生体活性骨移植片や合成骨移植片の開拓など、移植片材料や手術手技における技術革新は、用途を拡大し、骨移植手術の結果を改善しており、予測期間中に市場成長の新たな道を開くと期待されています。例えば、生体活性ガラスやセラミックなどの生体活性材料は、骨再生を促進する能力により人気を集めています。さらに、2020年には米国食品医薬品局が整形外科手術や脊椎手術における骨治癒を促進するように設計された新規の合成骨移植代替物を承認しており、これは市場における継続的な進歩と規制当局の支援を反映しています。

世界の骨移植片と代替物市場は、タイプ、用途、エンドユーザー、地域に区分されます。タイプ別では、同種移植片、代替物移植片、細胞ベースのマトリックスに分類されます。用途別では、脊椎固定、外傷、頭蓋顎顔面外科、関節再建、歯科骨移植に分けられます。エンドユーザー別では、病院、専門クリニック、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されています。

主要調査結果

タイプ別では、骨移植代替品セグメントが2023年に最大のシェアを占めました。

用途別では、脊椎固定セグメントが2023年に最大の骨移植片と代替物市場規模を占め、2033年支配的な地位を維持すると予測されます。

エンドユーザー別では、病院セグメントが2023年の主要株主でした。

地域別では、北米が2023年に市場シェアを獲得し、予測期間中もこの傾向が続くと予測されています。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 国、地域、世界レベルでの患者/疫学データ
  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 骨移植片と代替物市場：タイプ別

  • 市場概要
  • 同種移植片
    • 機械加工移植片
    • 脱灰骨マトリックス
  • 代替骨移植片
    • 骨形成タンパク質（BMP）
    • 合成骨移植片
  • 細胞ベースマトリックス

第5章 骨移植片と代替物市場：用途別

  • 市場概要
  • 脊椎固定
  • 外傷
  • 関節再建
  • 歯科用骨移植
  • 頭蓋顎顔面

第6章 骨移植片と代替物市場：エンドユーザー別

  • 市場概要
  • 病院
  • 専門クリニック
  • その他

第7章 骨移植片と代替物市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の骨移植片と代替物市場
    • カナダの骨移植片と代替物市場
    • メキシコの骨移植片と代替物市場
  • 欧州
    • 主要市場動向と機会
    • フランスの骨移植片と代替物市場
    • ドイツの骨移植片と代替物市場
    • イタリアの骨移植片と代替物市場
    • スペインの骨移植片と代替物市場
    • 英国の骨移植片と代替物市場
    • その他の欧州の骨移植片と代替物市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の骨移植片と代替物市場
    • 日本の骨移植片と代替物市場
    • インドの骨移植片と代替物市場
    • 韓国の骨移植片と代替物市場
    • オーストラリアの骨移植片と代替物市場
    • その他のアジア太平洋の骨移植片と代替物市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの骨移植片と代替物市場
    • 南アフリカの骨移植片と代替物市場
    • サウジアラビアの骨移植片と代替物市場
    • その他のラテンアメリカ・中東・アフリカの骨移植片と代替物市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Arthrex, Inc
  • Johnson And Johnson
  • Medtronic Plc
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Baxter International Inc.
  • Xtant Medical Holdings, Inc.
  • Integra LifeSciences
  • Orthofix Holdings, Inc.
目次
Product Code: A01446

The bone grafts and substitutes market was valued at $2.8 billion in 2023, and is projected to reach $4.4 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Bone grafts and substitutes are devices that are used to replace missing or damaged bone in various medical procedures. They play a crucial role in orthopedics and spinal surgeries. The primary purpose of bone grafts and substitutes is to support the body's natural healing process by providing a scaffold for new bone growth, enhancing the repair and regeneration of bone tissue. Thus, bone grafts and substitutes serve as vital tools in modern medicine, significantly improving patient outcomes in various surgical disciplines.

The growth of the global bone grafts and substitutes market is majorly driven by alarming increase in incidence of orthopedic conditions and rise in cases of fractures and sports injuries. A study published by Wolters Kluwer, a Dutch information services company, stated that approximately two million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, surge in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible to bone-related disorders such as osteoporosis and arthritis. This is attributed to the fact that minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, shift in preference toward minimally invasive surgical techniques, which often involve bone grafts and substitutes, is notably contributing to the market growth. In addition, increase in healthcare expenditure, especially in developing regions, is improving the access to advanced orthopedic treatments, including bone grafting procedures, which acts as a significant driving force of the global market. However, high cost associated with bone grafting procedures and risk of immune rejection act as the key deterrent factors of the global market. On the contrary, innovations in graft materials and surgical techniques, such as the development of bioactive and synthetic bone grafts, have expanded the applications and improved the outcomes of bone grafting procedures, which are expected to open new avenues for the growth of the market during the forecast period. For instance, bioactive materials, such as bioactive glass and ceramics, are gaining traction due to their ability to enhance bone regeneration. Moreover, in 2020, the U.S. Food and Drug Administration approved a novel synthetic bone graft substitute designed to enhance bone healing in orthopedic and spinal surgeries, reflecting ongoing advancements and regulatory support in the market.

The global bone grafts and substitutes market analysis is segmented into type, application, end user, and region. On the basis of type, the market is categorized into allografts, bone grafts substitute, and cell-based matrices. Depending on application, it is divided into spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction, and dental bone grafting. By end user, it is classified into hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the bone grafts substitute segment accounted for the largest share in 2023.

Depending on application, the spinal fusion segment occupied largest bone grafts and substitutes market size in 2023, and is expected to remain dominant by 2033.

By end user, the hospitals segment was the major shareholder in 2023.

Region wise, North America garnered market share in 2023, and is anticipated to continue this trend during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bone grafts and substitutes market include Arthrex, Inc, Johnson & Johnson, Medtronic plc, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings, Inc., Integra LifeSciences, and Orthofix Holdings, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Allografts
    • Machined allografts
    • Demineralized bone matrix
  • Bone grafts substitutes
    • Bone morphogenic proteins (BMP)
    • Synthetic bone grafts
  • Cell based matrices

By Application

  • Spinal fusion
  • Trauma
  • Joint reconstruction
  • Dental bone grafting
  • Craniomaxillofacial

By End User

  • Hospitals
  • Specialty clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Arthrex, Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive, Inc.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Baxter International Inc.
    • Xtant Medical Holdings, Inc.
    • Integra LifeSciences
    • Orthofix Holdings, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Allografts
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Machined allografts
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Demineralized bone matrix
      • 4.2.6.1. Market Size and Forecast
  • 4.3. Bone Grafts Substitutes
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
    • 4.3.5. Bone morphogenic proteins (BMP)
      • 4.3.5.1. Market Size and Forecast
    • 4.3.6. Synthetic bone grafts
      • 4.3.6.1. Market Size and Forecast
  • 4.4. Cell Based Matrices
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Spinal Fusion
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Trauma
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Joint Reconstruction
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Dental Bone Grafting
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Craniomaxillofacial
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bone Grafts and Substitutes Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bone Grafts and Substitutes Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bone Grafts and Substitutes Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Bone Grafts and Substitutes Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Bone Grafts and Substitutes Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Bone Grafts and Substitutes Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Bone Grafts and Substitutes Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Bone Grafts and Substitutes Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bone Grafts and Substitutes Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Bone Grafts and Substitutes Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Bone Grafts and Substitutes Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Bone Grafts and Substitutes Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Bone Grafts and Substitutes Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Bone Grafts and Substitutes Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bone Grafts and Substitutes Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bone Grafts and Substitutes Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Bone Grafts and Substitutes Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Bone Grafts and Substitutes Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bone Grafts and Substitutes Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Arthrex, Inc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Johnson And Johnson
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Medtronic Plc
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. NuVasive, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Stryker Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Zimmer Biomet Holdings, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Baxter International Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Xtant Medical Holdings, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Integra LifeSciences
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Orthofix Holdings, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments